Home Healthcare Market worth $298.2 billion by 2026

Chicago, June 07, 2022 (GLOBE NEWSWIRE) — According to the new market research report “Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication (Cancer, Wound Care, Diabetes), & Region – Global Forecast to 2026″, size was valued at USD 198.9 billion in 2021 and is projected to reach USD 298.2 billion by 2026 growing at a CAGR of 8.4% during the forecast period.

Browse in-depth TOC on “Home Healthcare Market”
419 – Tables
52 – Figures
438 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=696

Rapid growth in the elderly population, the rising incidence of chronic diseases, the growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements of home care devices are the major factors driving the growth of this market.

In 2020, the dialysis equipment segment accounted for the largest share of the home healthcare therapeutic products market

Based on therapeutic products, the global home healthcare market is segmented into oxygen delivery systems, nebulizers, ventilators, sleep apnea therapeutic devices, wound care products, IV equipment, dialysis equipment, insulin delivery devices, and other products (ostomy devices and automated external defibrillators). Dialysis equipment accounted for the largest share of the home healthcare therapeutic products market in 2020. Technological advancements and the launch of new products that are safe and easy to use in home care settings, and growing awareness about home therapies are some other major factors driving the growth of the home dialysis market

Home Healthcare Market Report Scope & Segmentation

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=696

Story continues

The diabetes indication segment is expected to grow at the highest CAGR during the forecast period

By indication type, the global home healthcare market is segmented into cancer, respiratory diseases, mobility disorders, cardiovascular diseases & hypertension, pregnancy, wound care, diabetes, hearing disorders, and other indications. The diabetes segment is expected to register the highest CAGR during the forecast period. The increasing number of diabetic patients mainly drives growth in this market. Moreover, monitoring blood sugar at home helps arrive at an overall diabetes treatment plan and aids in managing the medications for blood sugar, diet, and exercise.

North America was the largest regional market for the home healthcare market in 2020

The home healthcare market is segmented into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America was the largest regional market for home healthcare in 2020. The large share of North America in the global market is attributed to the high healthcare expenditure, rising prevalence of chronic conditions, high disposable income, the increasing overall geriatric population, high disposable income, and superior healthcare infrastructure. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. Growth in the Asia Pacific home healthcare market is driven primarily by the rising aging population, increased incidence of chronic diseases, rising disposable income, technological advancements, government initiatives to promote home healthcare, and increasing healthcare costs.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=696

The global home healthcare market is highly fragmented.

The prominent players in the overall home healthcare market include:

• Fresenius SE & Co. KGaA (Germany),

• GE Healthcare (US),

• Linde plc (Ireland),

• F. Hoffmann-La Roche Ltd (Switzerland),

• A&D Company (Japan),

• BAYADA Home Health Care (US),

• Invacare Corporation (US),

• Abbott (US),

• Amedisys (US),

• ResMed (US),

• LHC Group, Inc. (US),

• OMRON Corporation (Japan),

• Koninklijke Philips N.V. (Netherlands),

• Drive DeVilbiss Healthcare (US),

• Hamilton Medical (Switzerland),

• Sunrise Medical (Germany),

• Roma Medical (UK),

• Caremax Rehabilitation Equipment Co., Ltd (China),

• Vitalograph (UK),

• Advita Pflegedienst GmbH (Germany),

• RENAFAN GmbH (Germany),

• ADMR (France),

• Apex Medical Corporation (Taiwan),

• CONTEC MEDICAL SYSTEMS CO., LTD (China), and

• Löwenstein Medical Technology GmbH + Co. KG. (Germany).

Browse Adjacent [email protected] Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care) – Global Forecast to 2026

https://www.marketsandmarkets.com/Market-Reports/respiratory-care-368.html

Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitoring, MCOT, ECG, ICP, ILRs, Blood Glucose Monitoring, Blood Pressure Monitor), End-User (Hospitals, ASCs) – Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/patient-healthcare-monitoring-systems-devices-market-678.html

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [email protected]